These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36856394)

  • 21. Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    Kawada M; Nobeyama Y; Goto Y; Nakama K; Yamazaki N; Asahina A
    J Dermatol; 2020 Dec; 47(12):e424-e425. PubMed ID: 32815211
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic epidermal necrolysis in adult T cell leukemia/lymphoma treated with mogamulizumab.
    Tanba K; Uoshima N; Uchiyama H; Kawata E; Isa R; Yamaguchi J; Tsutsumi Y; Akaogi T; Kobayashi Y; Katsura K; Kuroda J; Taniwaki M
    Ann Hematol; 2016 Mar; 95(4):661-2. PubMed ID: 26754634
    [No Abstract]   [Full Text] [Related]  

  • 23. [Toxic epidermal necrolysis due to anti-PD1 treatment with fatal outcome].
    Demirtas S; El Aridi L; Acquitter M; Fleuret C; Plantin P
    Ann Dermatol Venereol; 2017 Jan; 144(1):65-66. PubMed ID: 28011090
    [No Abstract]   [Full Text] [Related]  

  • 24. Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome.
    Lazaridou I; Calvani J; Annabi E; Moins-Teisserenc H; Ta VA; Rivet J; Ram-Wolff C; Dumont M; Mahevas T; Vignon-Pennamen MD; Mourah S; Bouaziz JD; Louveau B; Bagot M; Battistella M; de Masson A
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e715-e717. PubMed ID: 36645855
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tislelizumab-Induced Toxic Epidermal Necrolysis-Like Cutaneous Adverse Reaction: Rare Complication of Immune Checkpoint Inhibitor Therapy.
    Yang X; Xu S
    Am J Ther; 2024 Jul-Aug 01; 31(4):e470-e474. PubMed ID: 38976533
    [No Abstract]   [Full Text] [Related]  

  • 27. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic epidermal necrolysis post apalutamide with preceding tislelizumab administration in a patient with two cancers.
    Wu W; Da M; Chen M; Wang F; Wu Y; Du Y; Sun L; Zhu X; Wang F
    J Dtsch Dermatol Ges; 2023 Oct; 21(10):1221-1223. PubMed ID: 37650770
    [No Abstract]   [Full Text] [Related]  

  • 29. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late onset toxic epidermal necrolysis induced by mogamulizumab, an anti-CC chemokine receptor 4 antibody for the treatment of adult T-cell leukaemia/lymphoma.
    Shiratori S; Ohhigashi H; Ito S; Kudo K; Adachi M; Minamimoto T; Kato J; Osai Y; Tsutsumi Y; Teshima T
    Hematol Oncol; 2017 Mar; 35(1):138-140. PubMed ID: 26177633
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stevens-Johnson Syndrome Induced by Pembrolizumab in a Lung Cancer Patient.
    Haratake N; Tagawa T; Hirai F; Toyokawa G; Miyazaki R; Maehara Y
    J Thorac Oncol; 2018 Nov; 13(11):1798-1799. PubMed ID: 29885481
    [No Abstract]   [Full Text] [Related]  

  • 33. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Lerner LH; Qureshi AA; Reddy BV; Lerner EA
    J Invest Dermatol; 2000 Jan; 114(1):196-9. PubMed ID: 10620138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing spectrum of suspected drugs of epidermal necrolysis: A World Health Organization pharmacovigilance database analysis from 1997-2020.
    Bettuzzi T; Ingen-Housz-Oro S; Purtillo CC; Le Cleach L; Maison P; de Prost N; Wolkenstein P; Lebrun-Vignes B; Sbidian E
    J Am Acad Dermatol; 2021 Dec; 85(6):1581-1584. PubMed ID: 33217509
    [No Abstract]   [Full Text] [Related]  

  • 36. Pembrolizumab-induced Stevens-Johnson Syndrome with Severe Ocular Complications.
    Ryu S; Jun I; Kim TI; Seo KY; Kim EK
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1533-1535. PubMed ID: 33826467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
    Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of six cases.
    Kara A; Devrim İ; Çağlar İ; Bayram N; Kundak S; Apa H; Altan EV
    Turk J Pediatr; 2019; 61(4):538-543. PubMed ID: 31990471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.